Health Matters International Introduces Innovative Program to Help Women with the High Costs of Fertility Drugs and Associated IVF Treatments
Since most insurance or government programs do not cover infertility treatments, there is an overwhelming need for quality, affordable infertility medications, IVF, and other forms of treatment. Health Matters International provides a solution to this often stressful issue.
Calgary, Alberta (PRWEB) April 21, 2012
Health Matters International announces a two-pronged solution geared to provide more affordable infertility treatment and medications. Langdon Drugs, Ltd, the pharmacy division of HMI, introduces significant discounts on fertility medications from their US, Canadian and other certified, accredited international pharmacies. Many couples have to deplete their savings in order to pay for the necessary fertility drugs and this adds even more stress to undergoing treatment options with no guaranteed outcomes.
According to the Center for Disease Control, CDC, the number of US women ages 15-44 with impaired fecundity is 11% or 7.3 million. Most cases of infertility are caused by problems with ovulation. Without ovulation, there are no eggs to be fertilized.
The American Society of Reproductive Medicine (ASRM) reports that the average cost of one IVF cycle using fresh embryos (not including medications) is $8,158. Medications for In-Vitro Fertilization (IVF) are $3.000-$5,000 per fresh cycle on the average.
When asked how age affects a woman’s ability to have children, The Center for Disease Control and Prevention (CDC) says, “many women are waiting until their 30s and 40s to have children. In fact, about 20% of women in the United States now have their first child after age 35. So age is a growing cause of fertility problems. About one-third of couples in which the woman is older than 35 years have fertility problems.”
The Medical Travel Division of Health Matters International, SurgicalEscape, is in partnership with a world-renown facility in Barbados which recently received the Gold Seal of Approval from the Joint Commission International (JCI), the US health facility accreditation program that sets health care industry standards.
Infertility is a stressful time for couples and many studies reflect the negative impact this has on success. The world-class medical service combined with personalized care and a beautiful setting has resulted in higher success outcomes than in most other facilities. In addition to higher overall outcomes, the average cost is also much lower than most facilities in the US, Canada or many other countries.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebIn-Vitro/Fertilization/prweb9360931.htm